Literature DB >> 31032270

Acupuncture combined with herbal medicine versus herbal medicine alone for plaque psoriasis: a systematic review protocol.

Shiju Xiao1,2, Bo Li3, Shuo Feng3, Cunzhi Liu4, Guangzhong Zhang1.   

Abstract

BACKGROUND: Psoriasis is a condition with a multifactorial etiopathogenesis worldwide, and plaque psoriasis, which is characterized by redness, thickness, and scaling, is the most common kind. Individuals living with psoriasis show low levels of life quality, and having fewer or less extensive lesions may improve spiritual and mental health. Therefore, our objective is to explore the effectiveness of acupuncture combined with herbal medicine for plaque psoriasis and to compare acupuncture combined with herbal medicine with herbal medicine alone.
METHODS: Databases including PubMed, MEDLINE, the Cochrane Library, Excerpta Medica (EMBASE), the Chinese Biomedical Literature Database (CBM), the China National Knowledge Infrastructure Database (CNKI), the Wanfang database and the Chinese Scientific Journal Database (VIP database) will be searched from inception to March 2018. We will employ hand searches, and grey literature will also be obtained. Only randomized controlled trials evaluating acupuncture combined with herbal medicine to treat plaque psoriasis in adults will be assessed. The Psoriasis Area and Severity Index score (PASI score), the itching index, the life quality scores, and the anxiety index will be the outcome measures. Two independent reviewers will select the articles included, assess the risk of bias and extract data according to the inclusion criteria. A third reviewer will resolve disagreements. The purpose of this study will be to identify the effect of acupuncture combined with herbal medicine on the lesions (PASI score), symptoms (itching index, life quality scores) and mental status (anxiety index) of the patients. DISCUSSION: The meta-analysis will retrospectively examine current evidence regarding the effectiveness of the practice of acupuncture combined with herbal medicine to treat plaque psoriasis. This study may reveal, for the first time, an adjuvant therapy for psoriasis. TRIAL REGISTRATION: As the study is a systematic review protocol, trial registration will not be necessary. An article containing the results will be published in a peer-reviewed journal and disseminated through scientific conferences.

Entities:  

Keywords:  Acupuncture; herbal medicine; meta-analysis; protocol; psoriasis

Year:  2019        PMID: 31032270      PMCID: PMC6465449          DOI: 10.21037/atm.2018.09.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  21 in total

1.  Psoriasis from the patient's point of view.

Authors:  A Y Finlay
Journal:  Arch Dermatol       Date:  2001-03

2.  [Psoriasis: assessment of quality of life].

Authors:  J Ortonne
Journal:  Ann Dermatol Venereol       Date:  2000-09       Impact factor: 0.777

3.  Stigmatization and psoriasis.

Authors:  H L Richards; D G Fortune; C J Main; C E M Griffiths
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

4.  A classification of psoriasis vulgaris according to phenotype.

Authors:  C E M Griffiths; E Christophers; J N W N Barker; R J G Chalmers; S Chimenti; G G Krueger; C Leonardi; A Menter; J-P Ortonne; L Fry
Journal:  Br J Dermatol       Date:  2007-02       Impact factor: 9.302

5.  S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.

Authors:  Alexander Nast; Wolf-Henning Boehncke; Ulrich Mrowietz; Hans-Michael Ockenfels; Sandra Philipp; Kristian Reich; Thomas Rosenbach; Adel Sammain; Martin Schlaeger; Michael Sebastian; Wolfram Sterry; Volker Streit; Matthias Augustin; Ricardo Erdmann; Joachim Klaus; Joachim Koza; Siegrid Muller; Hans-Dieter Orzechowski; Stefanie Rosumeck; Gerhard Schmid-Ott; Tobias Weberschock; Berthold Rzany
Journal:  J Dtsch Dermatol Ges       Date:  2012-03       Impact factor: 5.584

Review 6.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

7.  Deleterious effects of traditional Chinese medicine preparations on the course of psoriasis--a case report.

Authors:  Aldona Pietrzak; Joanna Bartosińska; Jacob Dreiher; Jacek C Szepietowski; Urszula Gawlik-Dziki; Ryszard Maciejewski; Monika Podhorecka; Grażyna Chodorowska
Journal:  Ann Agric Environ Med       Date:  2013       Impact factor: 1.447

8.  Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.

Authors:  S P McKenna; S A Cook; D Whalley; L C Doward; H L Richards; C E M Griffiths; D Van Assche
Journal:  Br J Dermatol       Date:  2003-08       Impact factor: 9.302

9.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

Review 10.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence.

Authors:  Rosa Parisi; Deborah P M Symmons; Christopher E M Griffiths; Darren M Ashcroft
Journal:  J Invest Dermatol       Date:  2012-09-27       Impact factor: 8.551

View more
  2 in total

Review 1.  Mind-Body Interventions as Alternative and Complementary Therapies for Psoriasis: A Systematic Review of the English Literature.

Authors:  Teodora Larisa Timis; Ioan Alexandru Florian; Daniela Rodica Mitrea; Remus Orasan
Journal:  Medicina (Kaunas)       Date:  2021-04-23       Impact factor: 2.430

2.  Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways.

Authors:  Aimin Liu; Buxin Zhang; Wei Zhao; Yuanhui Tu; Qingxing Wang; Jing Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.